Nicolas von Beckerath Selected Research

Nicolas von Beckerath Research Topics

Disease

16	Coronary Artery Disease (Coronary Atherosclerosis) 05/2010 - 06/2002
11	Myocardial Infarction 02/2010 - 06/2002
10	Thrombosis (Thrombus) 02/2010 - 06/2002
3	ST Elevation Myocardial Infarction 01/2021 - 01/2008
3	Acute Coronary Syndrome 07/2009 - 05/2004
2	Pathologic Constriction (Stenosis) 01/2015 - 06/2003
2	Inflammation (Inflammations) 12/2010 - 11/2003
2	Hemorrhage 07/2010 - 02/2010
2	Infarction (Infarctions) 04/2006 - 10/2005
2	Stable Angina 10/2005 - 05/2004
1	False Aneurysm (Pseudoaneurysm) 04/2014
1	Stroke (Strokes) 05/2013
1	Carotid Artery Diseases 05/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2011
1	Necrosis 02/2009
1	Overweight 07/2007
1	Coronary Disease (Coronary Heart Disease) 04/2006
1	Diabetes Mellitus 08/2005
1	Atrial Fibrillation 09/2004
1	Unstable Angina 05/2004
1	Ischemia 06/2003

Drug/Important Bio-Agent (IBA)

12	Clopidogrel (Plavix)FDA Link 05/2010 - 10/2004
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2006 - 03/2005
2	Coe Comfort (FITT)IBA 01/2021 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 12/2010 - 10/2005
2	Adenosine Diphosphate (ADP)IBA 02/2010 - 07/2007
2	Cytochrome P-450 CYP2C19IBA 02/2010 - 04/2009
2	Thromboplastin (Tissue Factor)IBA 07/2009 - 11/2004
2	Interleukin-10 (Interleukin 10)IBA 02/2009 - 11/2003
2	pro-brain natriuretic peptide (1-76)IBA 04/2006 - 10/2005
2	oxidized low density lipoproteinIBA 10/2005 - 09/2005
2	Abciximab (ReoPro)FDA Link 12/2004 - 01/2004
2	G-protein beta3 subunitIBA 09/2004 - 03/2003
1	Thrombin FDA Link 04/2014
1	Thioredoxin-Disulfide ReductaseIBA 05/2011
1	Penicillins (Penicillin)FDA Link 07/2010
1	Phenprocoumon (Liquamar)FDA Link 05/2010
1	CytochromesIBA 02/2010
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2009
1	Interleukin-6 (Interleukin 6)IBA 02/2009
1	Interleukin-8 (Interleukin 8)IBA 02/2009
1	CytokinesIBA 02/2009
1	Natriuretic PeptidesIBA 04/2006
1	C-Reactive ProteinIBA 04/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2005
1	Sirolimus (Rapamycin)FDA Link 08/2005
1	Phenobarbital (Luminal)FDA Link 08/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2005
1	Messenger RNA (mRNA)IBA 11/2004
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2004
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2004
1	Ferritins (Ferritin)IBA 05/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2004
1	Integrin beta3 (GPIIIa)IBA 01/2004
1	ABO Blood-Group SystemIBA 01/2004
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2003
1	Differentiation AntigensIBA 06/2002

Therapy/Procedure

9	Stents 05/2013 - 06/2003
7	Percutaneous Coronary Intervention 01/2021 - 12/2004
6	Therapeutics 01/2015 - 01/2004
2	Electrodes (Electrode) 01/2010 - 03/2009
2	Drug-Eluting Stents 03/2009 - 08/2005
1	Endovascular Procedures 01/2015
1	Endarterectomy (Thromboendarterectomy) 05/2013
1	Carotid Endarterectomy 05/2013
1	Aftercare (After-Treatment) 10/2005